Communiqués Optimi Health Corp.

Actions

OPTI

CA68405H1001

Marché Fermé - Canadian Securities Exchange Autres places de cotation 21:59:48 07/06/2024			Varia. 5j.	Varia. 1 janv.
0,41 ^CAD	-6,82%		-4,65%	+67,35%

03/06	Optimi Health en hausse de 12% après avoir reçu une licence d'établissement de médicaments de Santé Canada	MT
31/05	Optimi Health Corp. annonce ses résultats pour le deuxième trimestre et les six mois terminés le 31 mars 2024	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Canadian Investment Regulatory Organization Trade Resumption - OPTI	03/06	AQ
Optimi Health Awarded Drug Establishment Licence From Health Canada	03/06	AQ
Canadian Investment Regulatory Organization Trading Halt - OPTI	03/06	AQ
Optimi Health Announces Closing of Fully Subscribed $1,500,000 Financing	31/05	AQ
Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules	29/05	GL
Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules	29/05	AQ
Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder	22/05	GL
Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder	22/05	AQ
Proactive: Optimi Health validates GMP process for MDMA capsules	16/05	PU
Stockhouse: Optimi Health makes first international MDMA shipment	16/05	PU
Optimi Health : Lululemon Scion JJ Wilson Plots to Make Psychedelic Drugs the New Yoga	15/05	PU
Optimi Health : CEO Bill Ciprick to present at 4th Annual Psychedelic Therapeutics & Drug Development Conference in Boston	15/05	PU
Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules	14/05	GL
Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules	14/05	AQ
Optimi Health Provides Corporate Update	10/05	GL
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research	09/05	GL
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research	23/04	GL
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)	15/04	GL
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)	15/04	AQ
Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute	09/04	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Optimi Health Corp.

Actions

OPTI

CA68405H1001

Communiqués

Filtres